Literature DB >> 18368408

Catalase -262C>T polymorphism in systemic lupus erythematosus in Poland.

Teresa Warchoł1, Margarita Lianeri, Mariusz Wudarski, Jan K Łacki, Paweł P Jagodziński.   

Abstract

It has been reported that reactive oxygen species contribute to pathogenesis of systemic lupus erythematosus (SLE). Catalase (CAT) -330C>T transition, known also as -262C>T, generates three genotypes. The CAT -330CC genotype is associated with a significantly lower CAT expression in comparison to -330CT and -330CT genotypes. Therefore, using restriction length fragment polymorphism analysis, we compared the frequencies of CAT -330C>T polymorphic variants between SLE patients (n = 102) and controls (n = 199). We did not observe significant differences in the prevalence of CAT -330C>T polymorphic variants in SLE patients and controls. However, we found that the CAT -330CC genotype (recessive model) showed a significant association with thrombocytopenia OR = 7.314 (1.977-27.057, P = 0.0017). We also observed that the CAT -330CC genotype (recessive model) is linked with leukopenia OR = 3.232 (1.361-7.676, P = 0.0118), renal manifestations OR = 2.403 (1.085-5.321, P = 0.0471) and presence of anti-snRNP Ab OR = 4.206 (95% CI = 1.405-12.590, P = 0.0131), and anti-Scl-70 Ab, OR = 3.143 (95% CI = 1.171-8.433, P = 0.0343) in SLE patients. Our findings suggest that the CAT -330CC genotype may contribute to some clinical manifestations in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368408     DOI: 10.1007/s00296-008-0569-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  28 in total

Review 1.  Reactive oxygen species as mediators of tissue protection and injury.

Authors:  V Bauer; F Bauer
Journal:  Gen Physiol Biophys       Date:  1999-10       Impact factor: 1.512

2.  Serum oxidant/antioxidant status of patients with systemic lupus erythematosus.

Authors:  Seyithan Taysi; Mustafa Gul; Refik Ali Sari; Fatih Akcay; Nuri Bakan
Journal:  Clin Chem Lab Med       Date:  2002-07       Impact factor: 3.694

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Reactive oxygen species expose cryptic epitopes associated with autoimmune goodpasture syndrome.

Authors:  R Kalluri; L G Cantley; D Kerjaschki; E G Neilson
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

5.  Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate.

Authors:  V Nilakantan; B T Spear; H P Glauert
Journal:  Carcinogenesis       Date:  1998-04       Impact factor: 4.944

6.  Expression of human endogenous retrovirus clone 4-1 may correlate with blood plasma concentration of anti-U1 RNP and anti-Sm nuclear antibodies.

Authors:  Piotr C Piotrowski; Sergiusz Duriagin; Paweł P Jagodzinski
Journal:  Clin Rheumatol       Date:  2005-07-13       Impact factor: 2.980

7.  Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia.

Authors:  S L Nuttall; S Heaton; M K Piper; U Martin; C Gordon
Journal:  Rheumatology (Oxford)       Date:  2003-02-28       Impact factor: 7.580

8.  Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  P Suryaprabha; U N Das; G Ramesh; K V Kumar; G S Kumar
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1991-08       Impact factor: 4.006

9.  Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.

Authors:  Peter Gergely; Craig Grossman; Brian Niland; Ferenc Puskas; Hom Neupane; Fatme Allam; Katalin Banki; Paul E Phillips; Andras Perl
Journal:  Arthritis Rheum       Date:  2002-01

10.  Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4+ T cells of patients with systemic lupus erythematosus.

Authors:  Radosław Januchowski; Mariusz Wudarski; Hanna Chwalińska-Sadowska; Paweł P Jagodzinski
Journal:  Clin Rheumatol       Date:  2007-05-11       Impact factor: 3.650

View more
  8 in total

1.  Polymorphic variants of antioxidative defense enzymes and their gene-gene epistatic interactions in systemic lupus erythematode patients.

Authors:  Tatjana Jevtovic Stoimenov; Milena Despotovic; Sonja Stojanovic; Jelena Basic; Dušica Pavlovic
Journal:  Clin Rheumatol       Date:  2017-07-15       Impact factor: 2.980

Review 2.  Interaction between glutathione and apoptosis in systemic lupus erythematosus.

Authors:  Dilip Shah; Sangita Sah; Swapan K Nath
Journal:  Autoimmun Rev       Date:  2012-12-29       Impact factor: 9.754

3.  CAT C-262T and GPX1 Pro198Leu polymorphisms in a Turkish population.

Authors:  H Sinan Suzen; Emel Gucyener; Ozgul Sakalli; Zuhal Uckun; Gulcin Kose; Duygu Ustel; Yalcin Duydu
Journal:  Mol Biol Rep       Date:  2009-05-08       Impact factor: 2.316

Review 4.  Oxidative stress and its biomarkers in systemic lupus erythematosus.

Authors:  Dilip Shah; Nidhi Mahajan; Sangita Sah; Swapan K Nath; Bishnuhari Paudyal
Journal:  J Biomed Sci       Date:  2014-03-17       Impact factor: 8.410

Review 5.  Haematological manifestations of lupus.

Authors:  Anum Fayyaz; Ann Igoe; Biji T Kurien; Debashish Danda; Judith A James; Haraldine A Stafford; R Hal Scofield
Journal:  Lupus Sci Med       Date:  2015-03-03

6.  CD4+CD25-Foxp3+ T cells as a marker of disease activity and organ damage in systemic lupus erythematosus patients.

Authors:  Nermine El-Maraghy; Mona S Ghaly; Omar Dessouki; Samah Ismail Nasef; Lobna Metwally
Journal:  Arch Med Sci       Date:  2016-11-15       Impact factor: 3.318

Review 7.  The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus.

Authors:  Michelle T Barati; Dawn J Caster
Journal:  Metabolites       Date:  2022-02-06

Review 8.  Systemic Lupus Erythematosus: Pathogenesis at the Functional Limit of Redox Homeostasis.

Authors:  Jay Pravda
Journal:  Oxid Med Cell Longev       Date:  2019-11-26       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.